Seer Inc (SEER) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Seer Inc (SEER) has a cash flow conversion efficiency ratio of -0.064x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-15.44 Million) by net assets ($241.48 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Seer Inc net asset quality index to measure how much of total assets are equity-financed.
Seer Inc - Cash Flow Conversion Efficiency Trend (2018–2025)
This chart illustrates how Seer Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore investment intensity of Seer Inc to see how much of total assets are deployed in long-term investments.
Seer Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Seer Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Mosa Industrial Corp
TW:4564
|
-0.002x |
|
GRP Limited
NSE:GRPLTD
|
0.098x |
|
Barton Gold Holdings Ltd
AU:BGD
|
-0.316x |
|
Info Yatirim AS
IS:INFO
|
0.022x |
|
Bioxyne Ltd
AU:BXN
|
-0.064x |
|
Central Proteina Prima Tbk
JK:CPRO
|
0.013x |
|
CYGNUS Metals Ltd
AU:CY5
|
-0.033x |
|
Maywood Acquisition Corp. Class A Ordinary Shares
NASDAQ:MAYA
|
-0.002x |
Annual Cash Flow Conversion Efficiency for Seer Inc (2018–2025)
The table below shows the annual cash flow conversion efficiency of Seer Inc from 2018 to 2025. For the full company profile with market capitalisation and key ratios, see Seer Inc (SEER) total market value.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $259.31 Million | $-44.45 Million | -0.171x | -21.77% |
| 2024-12-31 | $327.57 Million | $-46.11 Million | -0.141x | +5.41% |
| 2023-12-31 | $396.90 Million | $-59.06 Million | -0.149x | -9.44% |
| 2022-12-31 | $446.99 Million | $-60.78 Million | -0.136x | -47.55% |
| 2021-12-31 | $502.92 Million | $-46.35 Million | -0.092x | -90.97% |
| 2020-12-31 | $431.61 Million | $-20.83 Million | -0.048x | +67.63% |
| 2019-12-31 | $87.68 Million | $-13.07 Million | -0.149x | +3.91% |
| 2018-12-31 | $29.98 Million | $-4.65 Million | -0.155x | -- |
About Seer Inc
Seer, Inc., a life sciences company, develops and commercializes products to decode the biology of the proteome to improve human health in the United States, China, Australia, Europe, Israel, Japan, and South Africa. The company offers Proteograph Product Suite, an integrated solution, which includes proprietary engineered nanoparticles, consumables, automation instrumentation, and data analysis … Read more